Position in PTCT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,256,140
-$16,682,698 QoQ
Shares Held
88,956
-74.7% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#85
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. PTCT ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,256,140 | 88,956 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $23,938,838 | 351,370 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,333,218 | 359,837 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,379,221 | 348,366 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,971,023 | 286,057 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,888,155 | 311,777 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,084,402 | 312,016 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,688,021 | 315,041 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,635,758 | 315,100 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $8,398,341 | 288,702 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $8,349,439 | 302,955 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,821,267 | 304,385 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $13,031,196 | 320,413 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $16,441,795 | 339,426 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,571,579 | 303,159 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,989,786 | 278,681 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,441,701 | 235,689 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,806,689 | 236,041 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,991,303 | 225,742 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,048,392 | 135,673 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,111,988 | 144,594 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $7,591,720 | 160,332 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $21,672,607 | 355,114 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $24,743,325 | 529,269 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $24,770,862 | 488,192 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $21,250,553 | 476,363 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||